Cardiomyopathy Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 18 and 75 years old.
- People who have been initially diagnosed with heart failure by a cardiology department and are scheduled to receive medication as part of their treatment.
- People with no history of structural heart disease, and whose Framingham score (a measure of heart disease risk) is below 5 — or, if the score is 5 or above, a blockage in the heart's arteries has been ruled out through specific heart tests.
- People whose kidneys are filtering at a rate of 50ml/min or above, as calculated using a standard formula called the Cockcroft-Gault formula.
- People whose heart pumping function (measured as LVEF) is 50% or higher, as assessed by an ultrasound of the heart.
- People whose heart's electrical timing measurement (QT interval) is below 470 milliseconds on a heart tracing test.
- People who are willing and able to provide written consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have acute or chronic kidney impairment, where the kidneys' filtering rate is below 50ml/min/1.73m².
- People who have a history of heart-related conditions such as confirmed blocked heart arteries, heart valve disease, disease of the heart muscle, a heart condition present from birth, or heart failure.
- People who have any reason they cannot safely undergo a cardiac MRI scan (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Meng Jiang, MD, PhD, RenJi Hospital, School of Medicine, Shanghai Jiantong University
Phone: 13788912766
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Heart Failure Incidence of Rare cardiomyopathy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.